Viewing Study NCT00304460


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 4:39 PM
Study NCT ID: NCT00304460
Status: COMPLETED
Last Update Posted: 2019-12-12
First Post: 2006-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module